Browse > Article

The Th17 and Autoimmune Arthritis  

Cho, Mi-La (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Heo, Yu-Jung (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Park, Jin-Sil (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Lee, Seon-Yeong (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Sung, Young-Chul (Biotech Center, Department of Life Science, Pohang University of Science and Technology)
Kim, Ho-Youn (Rheumatism Research Center (RhRC), The Catholic University of Korea)
Publication Information
IMMUNE NETWORK / v.7, no.1, 2007 , pp. 10-17 More about this Journal
Abstract
Autoimmune arthritis, such as rheumatoid arthritis (RA), is a chronic inflammatory disorder that primarily affects the joints and then results in their progressive destruction. Effector Th cells have been classified as Th1 and Th2 subsets based on their cytokine expression profiles and immune regulatory function. Another subset of T cells termed Th17 was recendy discovered and known to selectively produce IL-17. Also, Th17 was shown to be generated by TGF${\beta}$ and IL-6 and maintained by IL-23. IL-17 is a proinflammatory cytokine that is considered to involve the development of various inflammatory autoimmune diseases such as RA, asthma, lupus, and allograft rejection. IL-17 is present in the sera, synovial fluids and synovial biopsies of most RA patient. IL-17 activates RA synovial fibroblasts to synthesize IL-6, IL-8 and VEGF via PI3K/Akt and NF-${\kappa}B$ dependent pathway. IL-17 increases IL-6 production, collagen destruction and collagen synthesis. In addition, it not only causes bone resorption but also increases osteoclastogenesis and fetal cartilage destruction. Inhibition of the IL-17 production may contribute a novel therapeutic approach along with potent anti-inflammatory effect and with less immunosuppressive effect on host defenses.
Keywords
Autoimmune arthritis; IL-17; Th17;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Nishimoto N: Cytokine signal regulation and autoimmune disorders. Autoimmunity 38;359-367, 2005   DOI   ScienceOn
2 Laura Connell: New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 20;865-878, 2006   DOI   ScienceOn
3 Harrington LE, Mangan PR, Weaver CT: Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Immunology 18;349-356, 2006
4 Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA: IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23;513-522, 2003   DOI   ScienceOn
5 Constantinescu CS, Wysocka M, Hilliard B, Ventura ES, Lavi E, Trinchieri G, Rostami A: Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 161;5097-5104, 1998   PUBMED
6 Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201;233-240, 2005   DOI   ScienceOn
7 Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278;1910-1914, 2003   DOI   ScienceOn
8 Wolk, K, Sabat R: Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17;367-380, 2006   DOI   ScienceOn
9 Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ: Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116; 1317-1326, 2006   DOI   ScienceOn
10 Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR: The orphan nuclear receptor ROR${\gamma}$t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126;1121-1133, 2006   DOI   ScienceOn
11 Connell L, McInnes IB: New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 20;865-878, 2006   DOI   ScienceOn
12 Fujiwara M, Hirose K, Kagami S, Takatori H, Wakashin H, Tamachi T, Watanabe N, Saito Y, Iwamoto I, Nakajima H: T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J Allergy Clin Immunol 119;662-670, 2007   DOI   ScienceOn
13 Chabaud M, Durand J, Buchs N: Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis and Rheumatism 42;963-970, 1999   DOI   ScienceOn
14 Bau B, Haag J, Schmid E, Kaiser M, Gebhard PM, Aigner T: Bone morphogenetic protein-mediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes but not up-regulated or downregulated in osteoarthritic cartilage. J Bone Miner Res 17; 2141-2150, 2002   DOI   ScienceOn
15 Willenborg DO, Fordham S, Bernard C, CowdenWB, Ramshaw IA: IFN-gamma playsa critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157;3223-3227, 1996   PUBMED
16 Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6;1133-1141, 2005   DOI   ScienceOn
17 Villarino AV, Huang E, Hunter CA: Understanding the proand anti-inflammatory properties of IL-27. J Immunol 173;715-20, 2004   DOI   PUBMED
18 Iwakura Y, Ishigame H: The IL-23/IL-17 axis in inflammation. J Clin Invest 116;1218-1222, 2006   DOI   ScienceOn
19 Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H: Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203;2673-2682, 2006   DOI   ScienceOn
20 Kim HR, Cho ML, Kim KW, Juhn JY, Hwang SY, Yoon CH, Park SH, Lee SH, Kim HY: Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPKdependent signalling pathways. Rheumatology (Oxford) 46; 57-64, 2007   DOI   ScienceOn
21 Rohn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF: Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 36;2857-2867, 2006   DOI   ScienceOn
22 Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16; 779-790, 2002   DOI   ScienceOn
23 Marsland BJ, Nembrini C, Grun K, Reissmann R, Kurrer M, Leipner C, Kopf M: TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-{theta} signaling and promote autoimmune myocarditis. J Immunol 178;3466-3473, 2007   DOI
24 Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin-17: A T cellderived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42;963-970, 1999   DOI   ScienceOn
25 Kolls JK, Linden A: Interleukin-17 family members and inflammation. Immunity 21;467-476, 2004   DOI   ScienceOn
26 Lundy SK, Sarkar S, Tesmer LA, Fox DA: Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 13;202, 2007
27 Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, Huang S, Boissier MC, Fournier C: High susceptibility to collagen-induced arthritis in mice lacking IFN-$\gamma$. J Immunol 158;5504-5566, 1997
28 Clavel G, Valvason C, Yamaoka K, Lemeiter D, Laroche L, Boissier MC, Bessis N: Relationshipbetween angiogenesis and inflammation in experimental arthritis. Eur Cytokine Netw 17;202-210, 2006   PUBMED
29 Zheng W, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89;587-596, 1997   DOI   ScienceOn
30 Stamp LK, James MJ, Cleland LG: Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunol Cell Biol 82;1-9, 2004   DOI   ScienceOn
31 Hata K, Andoh A, Shimada M, Fujino S, Bamba S, Araki Y: IL-17 stimulates inflammatory responses via NF- kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 282;G1035-G1044, 2002   DOI
32 Findlay DM, Haynes DR: Mechanisms of bone loss in rheumatoid arthritis. Mod Rheumatol Aug 15;232-240, 2005   DOI
33 Olsen NJ, Stein CM: New drugs for rheumatoid arthritis. N Engl J Med 350;2167-2179, 2004   DOI   ScienceOn
34 Moseley TA, Haudenschild DR, Rose L, Reddi AH: Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14;155-174, 2003   DOI   ScienceOn
35 Hwang SY, Kim JY, Kim KW, Park MK, Moon YM, Kim WU, Kim HY: IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-$\kappa$B-and Arthritis Res Ther 6;120-128, 2004   DOI   ScienceOn
36 Koller MD: Targeted therapy in rheumatoid arthritis. Wien Med Wochenschr 156;53-60, 2006   DOI   ScienceOn
37 Nakae S, Iwakura Y, Suto H, Galli SJ: Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 2007 Heremans H, Dillien C, Groenen M, Martens E, Billiau A: Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-$\gamma$. Eur J Immunol 26;2393-2328, 1996   DOI   ScienceOn
38 Iwakura Y, Ishigame H: The IL-23/IL-17 axis in inflammation. J Clin Invest 116;1218-1222, 2006   DOI   ScienceOn
39 Afzali B, Lombardi G, Lechler RI, Lord GM: The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology 148;32-46, 2007   DOI   PUBMED   ScienceOn
40 Lubbets E, Koenders MI, van den Berg WB: The role of T-cell interukine-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7;29-37, 2005   DOI   ScienceOn
41 Bettelli E, Kuchroo VK: IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J Exp Med 201;169-171, 2005   DOI   ScienceOn
42 Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17;138-146, 1996   DOI   ScienceOn
43 Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6;1133-1141, 2005   DOI   ScienceOn
44 Aggarwal S, Gurney AL: IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 71;1-8, 2002   PUBMED
45 Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K,Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N: Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44;1003-1012, 2001   DOI   ScienceOn
46 Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGF$\beta$ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells. Immunity 24;179-189, 2006   DOI   ScienceOn
47 Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 8;445:648-651, 2007   DOI   ScienceOn
48 Leonard JP, Waldburger KE, Goldman SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181;381-386, 1995   DOI
49 Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S:T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183;2593-2603, 1996   DOI   ScienceOn
50 Lubberts E, Koenders MI, van den Berg WB: The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7;29-37, 2005   DOI   ScienceOn
51 Frohlich A, Marsland BJ, Sonderegger I, Kurrer M, Hodge MR, Harris NL, Kopf M: IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109;2023-2031, 2007   DOI   ScienceOn
52 Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441;235-238, 2006   DOI   ScienceOn
53 Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM, Blumenschein WM, McClanahan T, Brombacher F, Hurst SD, Kastelein RA, Cua DJ: IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204;161-170, 2007   DOI   ScienceOn
54 Martinus AM, van Boekel, Erik R Vossenaar, Frank HJ van den Hoogenand WaltherJvan Venrooij: Autoantibody systems in rheumatoid arthritis: specificity,sensitivity and diagnostic value. Arthritis Res 4;87-93, 2002   PUBMED
55 Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG: Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156;5-7, 1996   PUBMED
56 Beklen A, Ainola M, Hukkanen M, Gurgan C, Sorsa T, Konttinen YT: MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 86;347-351, 2007   DOI   ScienceOn
57 Muller-Ladner U, Pap T: Pathogenesis of RA: more than just immune cells. Z Rheumatol 64;396-401, 2005   DOI
58 Estelle Bettelli, Mohamed Oukka, Vijay K Kuchroo1: T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8;345-50, 2007   DOI   ScienceOn
59 Farber A, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L: Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156;5-87, 1996   PUBMED
60 Andoh A, Hata K, Araki Y, Fujiyama Y, Bamba T: Interleukin (IL)-4 and IL-17 synergistically stimulate IL-6 secretion in human colonic myofibroblasts, Int J Mol Med 10;631-634, 2002c   PUBMED
61 Chung Y, Yang X, Chang SH, Ma L, Tian Q, Dong C: Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res 16;902-907, 2006   DOI   ScienceOn
62 McGeachy MJ, Anderton SM: Cytokines in the induction and resolution of expermental autoimmune encephalomyelitis. Cytokine 32;81-84, 2005   DOI   ScienceOn
63 Kim KW, Cho ML, Park MK, Yoon CH, Park SH, Lee SH, Kim HY: Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaBdependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther 7;139-148, 2005
64 Andoh, S. Fujino, S. Bamba, Y. Araki, T. Okuno and T. Bamba: IL-17 selectively down-regulates TNF-alpha-induced RANTES gene expression in human colonic subepithelial myofibroblasts, J Immunol 169;1683-1687, 2002a   DOI   PUBMED
65 Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham Anderson J, Wu J, Ouyang W: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445;648-651, 2007   DOI   ScienceOn
66 Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6;1123- 1132, 2005   DOI   ScienceOn
67 Andoh S, Fujino T, Okuno Y, Fujiyama Y, Bamba T: Intestinal subepithelial myofibroblasts in inflammatory bowel diseases. J Gastroenterol 37;33-37, 2002b   PUBMED
68 Georg Schett: Rheumatoid arthritis: inflammation and bone loss. Wien Med Wochenschr 156;34-41, 2006   DOI
69 Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D: Macrophages in rheumatoid arthritis. Histol Histopathol 22;581-586, 2007   PUBMED
70 Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, deSauvage F, Cooper AM: IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 175;788-795, 2005   DOI
71 Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50;650-659, 2004   DOI   ScienceOn
72 Kageyama Y, Koide Y, Yoshida A, Uchijima M, Arai T, Miyamoto S, Ozeki T, Hiyoshi M, Kushida K, Inoue T: Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 161;1542-1548, 1998   PUBMED
73 Knauer J, Siegemund S, Muller U, Al-Robaiy S, Kastelein RA, Alber G, Straubinger RK: Borrelia burgdorferi potently activates bone marrow-derived conventional dendritic cells for production of IL-23 required for IL-17 release by T cells. FEMS Immunol Med Microbiol 49;353-363, 2007   DOI   ScienceOn
74 Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick DJ: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. Clin Invest 116;1310-1316, 2006   DOI   ScienceOn
75 Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Maththys P: Accelerated collagen-induced arthritis in IFN $\gamma$ receptor-deficient mice. J Immunol 158;5507-5513, 1997   PUBMED